function getval(val){
 var a1=val.replace(/<\/?.+?>/g,"");
 var a2=a1.replace(/ /g,"");
 return a2;
}
//document.write('http://wxzl.cogonline.com/html/CeShiZhuanLanYi/WenZhang/YiShiBaoDao/797.html');
wx.config({
debug:  false, 
appId: 'wx85d01b1d7184c45d',
timestamp: 1714507359,
nonceStr: 'hY6lrZmcGJelIURY',
signature: '91388227799c8e501804f308eccefb66211c0403',
jsApiList: [ 
   'checkJsApi', 
   'onMenuShareTimeline', 
   'onMenuShareAppMessage', 
   'onMenuShareQQ', 
   'onMenuShareWeibo'
]
});
wx.ready(function () { 
	wx.onMenuShareTimeline({  
	title: '低级别浆液性卵巢癌MAPK 通路改变与总生存期的关系', 
	link: 'http://wxzl.cogonline.com/html/CeShiZhuanLanYi/WenZhang/YiShiBaoDao/797.html',
	imgUrl: 'http://wxzl.cogonline.com/wp/logo.jpg',
	success: function () {
		//alert('fx-ok');
	},
	cancel: function () {
		//alert('fx-no');
	}
	});
	wx.onMenuShareAppMessage({  
		title: '低级别浆液性卵巢癌MAPK 通路改变与总生存期的关系', 
		link: 'http://wxzl.cogonline.com/html/CeShiZhuanLanYi/WenZhang/YiShiBaoDao/797.html',
		imgUrl: 'http://wxzl.cogonline.com/wp/logo.jpg',
		desc: getval('有假说认为，LGSOC是浆液性囊腺瘤或腺纤维瘤进展为SBOT和（或）浸润性癌的中间型病理学改变，而LGSOC的组织形态、分子通路与SBOT的相关度达到75%以上，有力支持了这一假说。Kurman等提出LGSOC的另一种发病机制，即输卵管上皮乳头状增生(papillary tubal hyperplasia，PTH)来源学说。认为LGSOC原发部位并非源于卵巢，证据为91%的LGSOC患者输卵管上皮存在乳头状增生性病变，由此推论PTH是浆液性肿瘤的癌前病变。通过慢性炎症诱导输卵管黏膜上皮增生，进而'),
		success: function () {
			//alert('fx-ok');
		},
		cancel: function () {
			//alert('fx-no');
		}
	});
});	
wx.error(function (res) {
	//alert(location.href.split('#')[0]);
	//alert('err:'+res.errMsg);  
});
if(location.href.indexOf("?") >= 1 ){
	location.href=location.href.substring(0,location.href.indexOf("?"));
}